Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial Comparing Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis

NCT04194710 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT04194710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04194710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial Comparing Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis
Lead sponsor
Corporacion Parc Tauli
Phase
Not applicable
Overall status
Unknown status
Start date
December 22, 2020
Completion date
December 1, 2023
Enrollment
86 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epicondylitis, lateral